Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

AbbVie Inc.

NYSE: ABBVHealthcare / Drug Manufacturers - Major / USA
87.20+1.65+1.93%Vol 6 418 1061Y Perf -16.38%
Jan 17th, 2019 16:00
BID86.50 ASK88.47
Open85.54 Previous Close85.55
Pre-Market85.20 After-Trading87.03
 -0.35 -0.41%  -0.17 -0.19%
Target Price
101.09 
Analyst Rating
Moderate Buy 2.50
Potencial %
15.93 
Finscreener Ranking
★★+     48.03
Insiders Trans % 3/6/12M
-100/-100/-86 
Value Ranking
★★★     50.63
Insiders Value % 3/6/12M
-100/-100/-98 
Growth Ranking
★★★★+     60.72
Insiders Shares Cnt. % 3/6/12M
-100/-100/-98 
Income Ranking
★★★     48.91
Market Cap (mil)131 168 
Earnings Rating
Sell
Price Range Ratio 52wk %
20.06 
Earnings Date
25th Jan 2019

Today's Price Range

85.4287.68

52wk Range

77.50125.86

5 Year PE Ratio Range

9.9065.10

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
4.33%
3 Months
-3.00%
6 Months
-7.63%
1 Year
-16.38%
3 Years
52.08%
5 Years
84.26%

Quotes

Name / TickerPriceChg.Chg.%
ABBV87.201.65001.93
AAPL155.860.92000.59
GOOG1 089.908.93000.83
MSFT106.120.74000.70
XOM72.130.49000.68
WFC49.230.29000.59
JNJ129.091.05000.82
FB148.300.76000.52
GE9.140.16001.78
JPM102.920.42000.41
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.90
Current Ratio
1.20
Long Term Debt to Total Capital
0.90
Total Debt to Equity
10.49
Interest Coverage
7.90
Leverage Ratio -65.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
75.20
EBIT Margin
31.20
EBITDA Margin
36.40
Pre-tax Profit Margin
25.30
Profit Margin
30.73
ValuationValueIndustryS&P 500US Markets
PE Ratio
18.20
PB Ratio
39.31
PS Ratios
5.37
Price to Cash Flow
11.00
Price to Free Cash Flow
27.40
Cash Flow Per Share
8.03
Price to Tangible Book
-2.93
Book Value per Share
-1.94
Enterprise Value (in ths.)
164 560 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
119.16
ROE last 12 Months
407.34
Return on Assets (5Y Avg)
6.66
ROA last 12 Months
11.22
Return on Capital (5Y Avg)
15.76
ROC last 12 Months
20.62
Return on invested Capital Q
6.01
Return on invested Capital Y
14.24
Assets Turnover
0.40
Receivables Turnover
4.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
24 448 000
Revenue per Share
16.25
Revenue Growth 3 Years
3.85
Revenue Growth 5 Years
7.59
DividendsValueIndustryS&P 500US Markets
Dividend Yield
5.05
Dividend Rate
4.28
Dividend Growth 3 Years
15.03
Dividend Growth 5 Years
15.55

Earnings HistoryEstimateReportedSurprise %
Q03 20182.012.146.47
Q02 20181.982.001.01
Q01 20181.801.873.89
Q04 20171.441.482.78
Q03 20171.391.411.44
Q02 20171.401.421.43
Q01 20171.261.281.59
Q04 20161.201.200.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR1.92-3.52Negative
12/2018 FY7.941.02Positive
3/2019 QR2.082.46Positive
12/2019 FY8.71-0.23Negative
Next Report Date25th Jan 2019
Estimated EPS Next Report1.91
Estimates Count7
EPS Growth Next 5 Years %13.80
Volume Overview
Volume6 418 106
Shares Outstanding (in ths.)1 504 220
Trades Count28 506
Dollar Volume506 162 557
Avg. Volume6 997 693
Avg. Weekly Volume5 848 223
Avg. Monthly Volume7 266 821
Avg. Quarterly Volume7 210 815

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

56%44%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (33.33 %)
5 (41.67 %)
5 (38.46 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
7 (58.33 %)
6 (50.00 %)
7 (53.85 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (8.33 %)
1 (8.33 %)
1 (7.69 %)
RatingModerate Buy
2.50
Moderate Buy
2.33
Moderate Buy
2.38

There are no comments yet.

News